Idacta-mab INT-001 represents the interesting therapeutic method for combating selected blood-related tumors. The immunoglobulin is a distinct mechanism of effect, specifically binding to CD38, an membrane antigen https://nicoleuukw510667.blog5.net/92062859/idacta-mab-int-001-the-new-immunoglobulin-during-testing